Peter is a Director of Modern Media Publishing and is the publisher for Modern Medicine Magazine.

Peter is a Director of Modern Media Publishing and is the publisher for Modern Medicine Magazine.

Tapentadol’s Strong Analgesic Properties

Tapentadol’s Strong Analgesic Properties

Pain is a disorder that everyone experiences and is often difficult to treat. Current drug treatment options for management of pain include opioids, nonsteroidal anti-inflammatory drugs, and paracetamol. Tapentadol is a novel, next generation, centrally acting analgesic with dual mechanism of action that offers analgesic efficacy that is similar to that provided by a pure MOR agonist, but with an improved side-effect profile.

Modern Medicine – Dec/Jan 2019

An Updated Guide to Contraception Long-acting reversible methods

An Updated Guide to Contraception Long-acting reversible methods

Long-acting reversible contraception (LARC) methods are highly acceptable and offer cost-effective, efficacious contraception. They are associated with a lower risk of unintended pregnancy than shorteracting contraceptive methods. The contraceptive implant and intrauterine contraceptives have similar high efficacies in both typical and perfect use with few absolute or relative contraindications and few serious risks associated with their use.

Modern Medicine – Dec/Jan 2019

Protect Your Patients, Warm Them Correctly

Protect Your Patients, Warm Them Correctly

The benefits of maintaining normothermia are well understood and form an important component of the perioperative process. However, with increasing pressure on hospitals to reduce costs and become more profitable, this treatment modality can take a backseat either because items such as forced air warming blankets are not reimbursed by medical funders or it forms part of the global fee for surgical procedures and is disregarded so as to cut costs.

Modern Medicine – Dec/Jan 2019

Oct/Nov 2018 Edition

We welcome you to come and read through our latest, Oct/Nov, edition of Modern Medicine.

This month we have a jam packed edition for you. Our features this month include; Oncology, Colon Cancer, Pain and many more.

We encourage all of our readers to complete the CPD questionnaire for this edition, this can be done on the answer-form included in the magazine, or on our website CPD system.

Modern Medicine, the journal that’s with you wherever you go.

Asthma, COPD and When They Coexist

Asthma, COPD and When They Coexist

Asthma and chronic pulmonary obstructive disease (COPD) are umbrella terms that describe disorders of the airways with diverse inflammatory pathways and pathophysiology. Recent advances in the understanding of the immunopathology of asthma have led to the emergence of biological agents that more precisely target disease pathways but will require a more precise understanding of those dysfunctional pathways. There are areas where the pathology and expression of airways disease in asthma and COPD overlap. The overlap between asthma and COPD presents important challenges in diagnosis as well as management.

Modern Medicine – Oct/Nov 2018

Challenges in the Treatment of Age-related Macular Degeneration

Challenges in the Treatment of Age-related Macular Degeneration

Age-related macular degeneration (AMD) is the fourth biggest cause of visual impairment. Early diagnosis and treatment with intravitreal injections of anti-VEGF drugs saves sight. The burden of such treatments may be challenging to patients and carers and may reduce adherence to therapy. Investigations of alternative therapeutic targets and modalities are providing promising results. New drugs are being developed that require fewer treatments, thereby improving treatment efficacy and reducing disease burden.

Modern Medicine – Oct/Nov 2018

Consider Etoricoxib in the Management of Arthritis

Consider Etoricoxib in the Management of Arthritis

Osteoarthritis (OA) and rheumatoid arthritis (RA) are common diseases worldwide, as well as leading causes of morbidity and disability that threaten human health.1,2 The primary objectives of treatment for patients with OA or RA are to control pain, improve function and reduce disability.3 Of all the strategies available for the treatment of OA and RA, nonsteroidal anti-inflammatory drugs (NSAIDs) are often prescribed to relieve pain and inflammation.

Modern Medicine – Oct/Nov 2018

Acute and Chronic Musculoskeletal Pain Pharmacological Management

Acute and Chronic Musculoskeletal Pain Pharmacological Management

Musculoskeletal pain is common and has significant consequences for affected patients and society as a whole. Musculoskeletal pain is not purely nociceptive; peripheral inflammation and central sensitisation processes, as well as neuropathic components, contribute. Management of patients with these conditions should be multimodal and multidisciplinary and follow principles of chronic disease management aiming for improved function. Nonopioid analgesics play an important role in the pharmacological management of patients. Opioids should be used with caution and only after careful consideration in patients with musculoskeletal pain. Adjuvants such as anticonvulsants and antidepressants may play a previously underestimated role in the management of patients with musculoskeletal pain.

Modern Medicine – Oct/Nov 2018

HPV DNA Screening Lengthens Testing Intervals

HPV DNA Screening Lengthens Testing Intervals

Cervical cancer, caused by persistent cervical infection by highrisk HPV and made worse by the HIV epidemic, remains an important cause of morbidity and mortality in South Africa. The SA HPV Advisory Board previously recommended HPV-based primary screening and now international support for this approach is also mounting in view of higher sensitivity. The main advantages for South Africa is the ability to safely increase screening interval and to test cervico-vaginal self-sampled specimens.

Modern Medicine – Oct/Nov 2018